Publications by authors named "David Heredia"

Claim this Profile
S
Stage I Non-Seminomatous Testicular Cancer: Long-Term Follow-Up with Surveillance Approach Post-Orchiectomy.
Jorge Martínez-Cedillo, Jorge Martínez-Cedillo, Diego A Díaz-García, César Infante-González, Beatriz Mota-Vega, David Heredia

Oncology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI.
David Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde, Edgar Varela Santoyo, Luis Lara-Mejía

Cancer Biomark· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer.
Ana Gonzalez-Ling, Oscar Galindo Vázquez, Marcos Espinoza Bello, Rebeca Robles, María Luisa Rascón-Gasca, David Heredia

Palliat Support Care· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancer.
Alejandro Avilés-Salas, Diana Flores-Estrada, Luis Lara-Mejía, Rodrigo Catalán, Graciela Cruz-Rico, David Heredia

Thorac Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
David Heredia, Luis Mas, Andres F Cardona, Víctor Oyervides, Rodrigo Motta Guerrero

Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs.
Oscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín, David Heredia, Andrés F Cardona

Cancer Biomark· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies.
Oscar Arrieta, Luis Lara-Mejía, Elysse Bautista-GonzÁlez, David Heredia, Jenny G Turcott

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brigatinib in -positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP).
David Heredia, Feliciano Barrón, Andrés F Cardona, Saul Campos, Jerónimo Rodriguez-Cid

Future Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.
Oscar Arrieta, Andrés F Cardona, Luis Lara-Mejía, David Heredia, Feliciano Barrón

Crit Rev Oncol Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward early diagnosis of lung cancer.
Ayman El-Baz, Georgy Gimelfarb, Robert Falk, Mohamed Abou El-Ghar, Sabrina Rainey, David Heredia

Med Image Comput Comput Assist Interv· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel 3D joint Markov-Gibbs model for extracting blood vessels from PC-MRA images.
Ayman El-Baz, Georgy Gimel'farb, Robert Falk, Mohamed Abou El-Ghar, Vedant Kumar, David Heredia

Med Image Comput Comput Assist Interv· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis